PIERONI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 1.336
EU - Europa 1.133
AS - Asia 582
AF - Africa 32
OC - Oceania 2
SA - Sud America 2
Totale 3.087
Nazione #
US - Stati Uniti d'America 1.324
CN - Cina 379
IE - Irlanda 292
IT - Italia 270
SE - Svezia 225
FI - Finlandia 110
TR - Turchia 93
DE - Germania 76
SG - Singapore 66
AT - Austria 43
CI - Costa d'Avorio 28
CZ - Repubblica Ceca 19
GB - Regno Unito 18
BE - Belgio 17
FR - Francia 17
IN - India 16
NL - Olanda 15
KR - Corea 12
CA - Canada 8
LU - Lussemburgo 8
ES - Italia 7
PK - Pakistan 4
PA - Panama 3
TW - Taiwan 3
UA - Ucraina 3
VN - Vietnam 3
AU - Australia 2
CH - Svizzera 2
EG - Egitto 2
GH - Ghana 2
HK - Hong Kong 2
SI - Slovenia 2
BG - Bulgaria 1
BR - Brasile 1
CL - Cile 1
CY - Cipro 1
HR - Croazia 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
ME - Montenegro 1
MX - Messico 1
NO - Norvegia 1
NP - Nepal 1
PL - Polonia 1
PT - Portogallo 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.087
Città #
Chandler 339
Dublin 290
Ann Arbor 146
Ashburn 98
Parma 82
Dearborn 72
Izmir 72
Shanghai 67
Nanjing 61
Princeton 57
Beijing 56
Helsinki 43
Wilmington 43
Bremen 40
Singapore 36
Vienna 35
Abidjan 28
Chicago 26
Kocaeli 21
New York 19
San Mateo 18
Hefei 17
Nanchang 17
Falls Church 16
Hebei 16
Shenyang 16
Milan 15
Brussels 14
Changsha 14
Guangzhou 14
Boardman 13
Jinan 13
Seattle 13
Brno 12
Jiaxing 12
Norwalk 12
Los Angeles 11
Houston 9
Bologna 8
Dallas 8
Des Moines 8
Fremont 8
Dalmine 6
Sassari 6
Woodbridge 6
Birmingham 5
Fairfield 5
Luxembourg 5
Modena 5
New Brunswick 5
Ningbo 5
Chongqing 4
Dordrecht 4
Haikou 4
Kunming 4
London 4
Pune 4
San Giuliano Milanese 4
Washington 4
Zhengzhou 4
Ahmedabad 3
Amstelveen 3
Beitou 3
Edinburgh 3
Florence 3
Gonzaga 3
Grafing 3
Gwanak-gu 3
Lucca 3
Ottawa 3
Panama City 3
Rockville 3
Rome 3
Sissa 3
Uppsala 3
Ancona 2
Angers 2
Antwerpen 2
Basel 2
Brisbane 2
Cairo 2
Carpi 2
Chengdu 2
Chiniot 2
Daejeon 2
Dong Ket 2
Evanston 2
Figline Valdarno 2
Formigine 2
Gijón 2
Hangzhou 2
Hong Kong 2
Huizhou 2
Kyiv 2
Lanzhou 2
Lattes 2
Ljubljana 2
Maddaloni 2
Madrid 2
Mira Loma 2
Totale 2.094
Nome #
Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants 139
Nuovi composti antimicrobici 135
Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant 101
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 86
Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets 85
Refining the structure−activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms 83
Rational Design, Synthesis and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella Typhimurium O-Acetylserine Sulfhydrylase 81
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 78
Inhibitors of the sulfur assimilation pathway in bacterial pathogens as enhancers of antibiotic therapy 73
Inhibition of Nonessential Bacterial Targets: Discovery of a Novel Serine O-Acetyltransferase Inhibitor 73
A competitive o‐acetylserine sulfhydrylase inhibitor modulates the formation of cysteine synthase complex 71
Antituberculosis agents: Beyond medicinal chemistry rules 70
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 68
Exploring the chemical space around N-(5-nitrothiazol-2-yl)-1,2,3-thiadiazole-4-carboxamide, a hit compound with serine acetyltransferase (SAT) inhibitory properties 67
Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target 67
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 66
Blocking cysteine biosynthesis in Salmonella typhimurium: the moonlighting enzyme CysK as a potential antibiotic target 65
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation 63
Inhibitors of O-Acetylserine Sulfhydrylase with a Cyclopropane-Carboxylic Acid Scaffold Are Effective Colistin Adjuvants in Gram Negative Bacteria 60
Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR 59
Design, Synthesis and Investigation onthe Structure–Activity Relationships of N-Substituted 2-Aminothiazole Derivatives as Antitubercular Agents 58
Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents 58
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases 58
Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery 54
Crystal structure of Aspergillus fumigatus AroH, an aromatic amino acid aminotransferase 54
Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics 53
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A 53
Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design 53
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 51
Sodium Hyaluronate Microparticles for Pulmonary Delivery of Anti-mycobacterial Drugs 50
In vitro digestion of zingiber officinale extract and evaluation of stability as a first step to determine its bioaccesibility 50
Towards the sustainable discovery and development of new antibiotics 48
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin 46
Derivatives of 3-isoxazolecarboxylic acid esters - a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis 43
Preliminary structure - Activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains 43
Challenging the drug-likeness dogma for new drug discovery in Tuberculosis 43
Biochemical characterization of Aspergillus fumigatus AroH, a putative aromatic amino acid aminotransferase 43
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry 43
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches 42
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 42
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 38
Synthesis of 7-desmethyl analogs of (+)- and (-)-huperzine A 38
Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1) 38
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation article 38
Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy 37
From 6-aminoquinolone antibacterials to 6-amino-7- thiopyranopyridinylquinolone ethyl esters as inhibitors of staphylococcus aureus multidrug efflux pumps 36
Structural analogs of huperzine A improve survival in guinea pigs exposed to soman 34
An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria 33
Indoleamides are active against drug-resistant mycobacterium tuberculosis 28
NOC chemistry for tuberculosis - Further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives 28
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 27
Synthesis and Structure-Activity Relationships of Lansine Analogues as Antileishmanial Agents 27
Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains 27
Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB 25
Searching for innovative quinolone-like scaffolds: Synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 24
Spectinamides: A challenge, a proof, and a suggestion 24
From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters 24
Mutation of Rv2887, a marR-Like gene, confers mycobacterium tuberculosis resistance to an imidazopyridine-based agent 23
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway 23
Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania 21
Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. A potent and selective series for further drug development 20
Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes 19
In pursuit of natural product leads: Synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4- carboxylic acid (A-33853) and its analogues: Discovery of N-(2-benzoxazol-2- ylphenyl)benzamides as novel antileishmanial chemotypes 18
Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics 12
Totale 3.237
Categoria #
all - tutte 14.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020337 0 56 3 7 42 74 47 8 27 49 17 7
2020/2021201 3 5 8 10 6 12 8 24 46 41 17 21
2021/2022379 15 28 25 25 10 38 20 26 35 22 21 114
2022/20231.261 118 138 79 100 146 149 7 65 374 15 41 29
2023/2024507 24 40 17 28 49 72 48 44 26 28 40 91
2024/202578 64 14 0 0 0 0 0 0 0 0 0 0
Totale 3.237